Single-Domain Antibody-Based TCR-Like CAR-T: A Potential Cancer Therapy.
Zhu L, Yang X, Zhong D, Xie S, Shi W, Li Y, Hou X, HuaYao, Zhou H, Zhao M, Ding Z, Zhao X, Mo F, Yin S, Liu A, Lu X.
Zhu L, et al. Among authors: lu x.
J Immunol Res. 2020 Sep 7;2020:2454907. doi: 10.1155/2020/2454907. eCollection 2020.
J Immunol Res. 2020.
PMID: 32964055
Free PMC article.
Review.